“Passionate but Undervalued”: The Hidden Burnout Crisis Facing Drug Treatment and Recovery Workers

They turn up every day to jobs that involve hearing accounts of trauma, watching people die, and carrying caseloads that far exceed safe limits. Yet England’s drug treatment and recovery workers are described, almost universally, as deeply committed to the people they serve. The question is how much longer that commitment can hold before the system breaks.

A new report published in 2026 by RAND Europe, funded by the National Institute for Health and Care Research (NIHR), offers the most detailed independent picture yet of what it actually feels like to work inside England’s treatment and recovery sector. The findings are sobering, and they carry serious implications not just for staff wellbeing, but for the people who depend on these services every day.

Caseloads That No Drug Treatment and Recovery Worker Should Carry

Best practice guidance recommends that drug treatment and recovery workers carry no more than 40 cases at a time. In practice, the RAND Europe report tells a very different story. Staff surveyed across ten case study sites reported individual caseloads ranging from 50 to 120 people.

This is not simply a workload issue. Care quality suffers directly when one worker holds responsibility for more than 100 people at once. Referrals get missed. Support becomes thin. Half of all survey respondents (50.7%) agreed they work very intensively, and more than a third (37.2%) said they regularly have to drop tasks because the volume of work is simply unmanageable.

One worker captured the breadth of what gets expected of them: “We are basically a care coordinator in every part of these clients’ lives, which makes it really challenging when you have got 60 clients on your caseload.”

Burnout Is Widespread Among Alcohol and Drug Treatment Staff

Nearly four in ten alcohol and drug treatment staff (38.7%) reported sometimes, often, or always feeling burnt out because of their work. Among workers who had been in the sector for three to five years, the rates were even higher.

What makes this figure so striking is that it sits alongside genuinely high levels of engagement. Some 92.4% of respondents described themselves as enthusiastic about their job. Staff are not checked out. Many are running on passion alone, which is not a sustainable substitute for proper resourcing.

The emotional weight of the role is hard to overstate. These workers attend inquests, support people through relapse, and absorb traumatic disclosures without always having the time or structure to decompress. One member of staff put it plainly: “Death is part of what we do.” Another described it as “heartbreaking sometimes watching people die.”

Compassion fatigue is a recognised risk in this field. As one LERO staff member told researchers: “To be in this job, you have to be empathetic, which means taking on how other people are feeling, and that just naturally drains your cup.”

Pay and Job Security Are Pushing People Out

Perhaps the most revealing finding in the report is this: it is not the nature of the work itself that drives people to leave. Workload, pay, and job insecurity are the real culprits, and all three are fixable.

Fewer than half of survey respondents (45.9%) said they were satisfied with their pay. The frustration is compounded by visible inequity within the same sector. At one case study site, NHS staff and third-sector staff doing equivalent roles were paid thousands of pounds apart annually, a gap that was widely known and widely resented.

“There are now people on my course and in my equivalent role working in the NHS that are on thousands of pounds more than me,” one staff member told researchers.

Short-term contracts make things worse. Much of the additional drug strategy funding has arrived in one-year tranches, creating a cycle where services are built up, only to face uncertainty almost immediately. One staff member described being forced to wind down a service that had barely launched: “We have got tons of referrals, tons of staffing wants, people to do… it is just too short.”

Commissioners have flagged the same issue from a planning perspective. When funding cycles are too short, long-term strategy becomes impossible.

A Supportive Culture That Is Starting to Crack

There are genuine strengths worth acknowledging. More than 83% of survey respondents said their colleagues were willing to listen to work-related problems, and a similar proportion reported strong managerial support. For many alcohol and drug treatment staff, the team around them is what keeps them going.

But this culture is not protected automatically. High turnover stretches those who remain. Bringing in less experienced workers, while necessary, adds to the burden on senior staff who must train and support them on top of full caseloads. Several workers described teams that once had seven or eight nurses now running with just one.

Expansion funded by the drug strategy has helped in some areas, enabling services to hire specialist roles and reduce caseloads. Yet fewer than half of respondents (45.9%) agreed they had enough staff to do their job properly. Progress is real, but it is fragile.

Career Development for Drug Treatment and Recovery Workers Remains Unclear

Clear career progression is one of the biggest gaps facing drug treatment and recovery workers in the third sector. Around a quarter of staff said they did not feel they had an achievable career pathway in their current role. Among that group, more than a third planned to look for a new job within the next 12 months.

Third-sector organisations largely lack the banding structures that give NHS careers a visible shape. Workers reach a ceiling early, and additional responsibility does not reliably come with additional pay. The result is that talented, experienced people move on, taking their knowledge with them.

Some providers have responded creatively. A number have developed in-house traineeships, accreditation schemes, and more visible promotion routes. One treatment service lead described plans to offer staff their own professional qualification linked to a university: “I think that will be transformational.”

These are promising signs. Across the sector, though, career development remains piecemeal.

The Moral Distress No One Is Talking About Enough

Beyond burnout, the report identifies something more specific: moral distress. This is the particular strain that comes from knowing what the right thing to do is, and being prevented from doing it.

Workers described sadness and frustration at not being able to offer medically-assisted withdrawal, specific medications, or even something as basic as a bus pass to someone who needed it. Others described conflict between their own values and the target-driven priorities of their organisations.

Repeated exposure to these situations, the report’s authors note, can harden into moral injury, a deeper and more lasting wound that ultimately pushes people out of the profession entirely. Addressing moral distress requires system-level change, not individual resilience.

Six Changes the Report Recommends

The RAND Europe report sets out six clear recommendations for government, local authorities, and providers:

• Establish longer funding timelines and commissioning cycles to give both services and staff genuine security.
• Expand investment in senior and supervisory positions so that less experienced staff have proper support.
• Develop clear career pathways for all roles within the sector, recognising the value of lived experience alongside formal qualifications.
• Review and address pay disparities between NHS and third-sector services, benchmarking against comparable roles elsewhere.
• Build a shared vision of care at the local level, so that gaps between organisations are filled and collaboration improves.
• Create a standardised approach to staff support, covering supervision, reflective practice, and emergency wellbeing mechanisms.

The Bigger Picture

England’s alcohol and drug treatment staff have absorbed more than a decade of underinvestment. The former government’s 10-year drug strategy, launched in 2022, began to turn the tide. The RAND Europe report is clear that the funding has been welcome and has made a real difference in some areas: more specialists hired, more services expanded, caseloads reduced in places.

In other areas, the money simply restored what had been cut. It did not build the system that drug treatment and recovery workers actually need.

The commitment of this workforce is, frankly, remarkable given what it faces. Fair pay, stable contracts, and a manageable caseload are not unreasonable things to ask for. Until those basics are in place, the exits will keep coming.

Source: dbrecoveryresources